Results 11 to 20 of about 1,639 (142)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies [PDF]

open access: yesScientific Reports, 2021
The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis.
Cristina Regueiro   +10 more
doaj   +6 more sources

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. [PDF]

open access: yesPLoS ONE, 2018
Carbamylation is a post-translational modification that mostly affects proteins with low turnover, such as dermal proteins. Carbamylated proteins accumulate in skin in an age-dependent manner, contributing to tissue alterations.
Elvira Favoino   +6 more
doaj   +6 more sources

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients [PDF]

open access: yesScientific Reports, 2017
Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics.
Cristina Regueiro   +9 more
doaj   +6 more sources

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein (anti-CarP) antibodies are rheumatoid arthritis (RA)-associated autoantibodies. Besides their presence in human serum, anti-CarP antibodies have
Marije K. Verheul   +4 more
doaj   +6 more sources

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties.
Myrthe A. M. van Delft   +8 more
doaj   +6 more sources

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients. [PDF]

open access: yesPLoS ONE, 2017
Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies.
Laura Vidal-Bralo   +7 more
doaj   +5 more sources

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. [PDF]

open access: yesRheumatology (Oxford), 2017
Anti-carbamylated protein (anti-CarP) antibodies are detected in RA patients. Fetal calf serum is used as an antigen source in anti-CarP ELISA, and the precise target antigens have not been found. We aimed to identify the target antigens of anti-CarP antibodies.Western blotting of anti-CarP antibodies was conducted.
Nakabo S   +16 more
europepmc   +5 more sources

Anti-Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap-Mediated Bone Loss in Rheumatoid Arthritis. [PDF]

open access: yesArthritis Rheumatol
Objective Carbamylation, a nonenzymatic post‐translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti‐carbamylated protein antibodies (anti‐CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought
Nakabo S   +9 more
europepmc   +2 more sources

Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis

open access: yesIndian Journal of Rheumatology, 2019
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset.
Ashraf H Mohamed   +6 more
doaj   +2 more sources

Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis [PDF]

open access: yesImmunological Medicine, 2019
Several autoantibodies against proteins with post-translational modifications have been detected in patients with rheumatoid arthritis (RA) and are called anti-modified protein antibodies (AMPAs).
Shuichiro Nakabo
doaj   +3 more sources

Home - About - Disclaimer - Privacy